Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL342P (RNA, 7SL, cytoplasmic 342, pseudogene) is a pseudogene—a nonfunctional genomic sequence similar to the gene encoding 7SL RNA, which is a component of the signal recognition particle (SRP) complex. Unlike functional SRP RNA genes (e.g., RN7SL1), RN7SL342P does not code for a functional RNA product and is not translated into protein or known to have a biological function. Pseudogenes like RN7SL342P are common in the human genome and generally arise from mutations or reverse transcription events resulting in sequence elements that resemble active genes but lack their function[1][3][4][5][7]. As such, RN7SL342P is not considered a therapeutic target, receptor, or enzyme, and there are no known drugs, disease associations, or biomarker roles associated with it. Its main scientific utility is as a reference point for studies of genomic evolution, RNA gene families, and the complexity of the human genome. Notes: - This entity is a pseudogene, not a receptor, enzyme, or bona fide protein-coding or regulatory RNA. - There is nothing to suggest it is a valid therapeutic target, nor does it have known biological or disease roles, mechanisms of action, or safety concerns[1][3][4][5][7]. - The entry may be misleading if thought to represent a functionally relevant therapeutic target or receptor—it does not[1][4]. Summary: RN7SL342P is a nonfunctional, pseudogene copy of the 7SL RNA gene, with no known therapeutic or biological relevance beyond its characterization as a genomic pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 342, pseudogene (RN7SL342P).